"page","tableheading","tablestart.pos","tablelastline","tableend.pos","legendlastline","legendend.pos","txtfirstline","detected.in"
"3","Table 1 Characteristics of all the enrolled data.","75","MAP vs MAP-M","115","trial.","154","3","txtandhtml"
"6","Table 2 Baseline characteristics of all enrolled p","196","0","320","MAP+ = MAP plus ifosfamide and etoposide, or other adjuvant therapy drugs, MAP = methotrexate, doxorubicin, and cisplatin.","321","Patients receiving chemotherapy (MAP or MAP+) had a better","txtandhtml"
